SEC Filings for Aridis Pharmaceuticals Inc. (ARDS)

$ 7.20   0.0433 (+0.61%) Volume: 2.03k 3:56 PM EDT Sep 29, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)3808/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)1008/11/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans907/28/2020
8-KCurrent report pursuant to Section 13 or 15(d)1106/26/2020
4/A[Amend] Statement of changes in beneficial ownership of securities106/25/2020
4Statement of changes in beneficial ownership of securities106/25/2020
8-KCurrent report pursuant to Section 13 or 15(d)706/22/2020
3Initial statement of beneficial ownership of securities106/17/2020
8-KCurrent report pursuant to Section 13 or 15(d)606/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/04/2020
424B5Prospectus [Rule 424(b)(5)]105/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)1005/12/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)3605/12/2020
8-KCurrent report pursuant to Section 13 or 15(d)1105/05/2020
DEF 14AOther definitive proxy statements4504/17/2020
<<
First
<
Prev
12345678